BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home
»
Topics
»
Drugs
» Immuno-oncology
Immuno-oncology
RSS
Phase III comparative trial of PEG-Intron and Intron A for CML completed
June 14, 2001
Extension of pemtumomab phase III trial announced following meeting with FDA
June 12, 2001
Dendreon expands phase III trials of Provenge for prostate cancer
June 12, 2001
GM-CSF gene therapy for metastatic melanoma enters clinical testing
June 11, 2001
Preliminary phase I data for Revimid show activity against solid tumors, good safety
June 8, 2001
Berlex commences launch of Campath in U.S.
June 7, 2001
Herceptin reaches market in Japan
June 5, 2001
Topical immune response modifier provides high response rate in phase II trial in sBCC
June 5, 2001
European authorities grant orphan drug designation for pemtumomab
June 5, 2001
Wilex antibody receives orphan drug status for RCC from FDA
June 1, 2001
Previous
1
2
…
924
925
926
927
928
929
930
931
932
…
1001
1002
Next
RSS